We are an independent, accredited trade organisation that supports UK international trade.
United Kingdom
Joined February 2009
- Tweets3.1K
- Following97
- Followers2.7K
- Likes3.7K
BioPartner UK retweeted
#Bionow partner @BioPartner negotiates entry fee #discounts for UK companies attending many major international #BiopharmaEvents. Bionow Members can claim discounts at the BioPartner Alliance Member rate, as well as join a BioPartner UK Delegation.
bionow.co.uk/purchasing-sche…
BioPartner UK retweeted
Scendea are hiring! Are you a skilled and motivated individual seeking a challenging and rewarding career? Discover our open vacancies and apply today: linkedin.com/company/scendea…
-
#drugdevelopment #regulatoryaffairsroles #hiring #lifeatscendea
BioPartner UK retweeted
We are proud to share that Scendea is now a certified B Corporation™! Watch our journey below and learn more about what being a B Corp means to Scendea.
-
#BCorp #BCorpCertified #BusinessAsAForceForGood #ESG #Sustainability #LifeAtScendea
BioPartner UK retweeted
EXHIBITORS: Boost your profile at the #Bionow #Neuroscience conference on 9 July, with #exhibitor packages starting at just £450, including 2 delegate passes. Get your company in front of academics, clinicians and industry leaders.
Find out more:
bionow.glueup.com/resources/…
BioPartner UK retweeted
The EMA has updated a series of assessment timetable documents relating to initial marketing authorisation applications. Get in touch to discuss how the updated EMA timetables may affect your strategy: scendea.com/contact
BioPartner UK retweeted
Our Chief Executive Officer Jeremy Skillington & Chief Financial Officer Ian O'Connell will be attending @IAmBiotech Bio International Convention, one of the world’s leading events for the biotechnology and life sciences industry.
📍San Diego, US
🗓️22-25 June 2026
With interim data from the POLB 001 TOPICAL trial expected this summer, alongside the recent Canadian patent grant, momentum continues to build across the programme. The team looks forward to engaging with potential partners at BIO to discuss the clinical progress, our expanding IP portfolio, and broader commercial opportunity ahead.
If you’re attending BIO 2026, connect with our team via the BIOpartnering platform.
Learn more:
convention.bio.org/
#POLB #BIO2026 #Biotech #LifeSciences #HealthcareInnovation #Biotechnology #Networking #Innovation #BIOInternational
BioPartner UK retweeted
🙏 A big thank you to the #ECB2026 sponsors & exhibitors!
Your support helps young scientists attend the congress through reduced registration fees 🧬🌍
Interested in becoming a sponsor or exhibitor?
🔗 ecb2026.com/sponsors-and-exh…
#Biotechnology #LifeSciences
ALT Thank you to ECB2026 sponsors and exhibitors.
BioPartner UK retweeted
LAST CHANCE TO BOOK: 💪 Empowering #WomenInBiotech 💪 is at BioCity Glasgow THIS THU so join #Bionow for this inclusive and FREE (for Members) #networking event sharing women's success stories from #academia, #biotech and #LifeSciences. ALL welcome!
bionow.glueup.com/event/empo…
BioPartner UK retweeted
To enhance our expertise in the Cytokine Release Syndrome space we have appointed Dr Adrian Kilcoyne to our Scientific Advisory Board.
Dr Kilcoyne bring over 20 years of clinical expertise with strategic drug development leadership, focusing on innovative therapies that address unmet medical needs in oncology and immunology and, in particular, brings deep knowledge of haematological malignancies, T-cell therapies and Cytokine Release Syndrome.
Adrian’s wealth of experience will provide further support to our established team of experts as we progress POLB 001 through the TOPICAL trial with the ultimate aim of transforming cancer care for patients and healthcare systems.
Learn more about Dr Kilcoyne’s experience and read the full announcement here:
londonstockexchange.com/news…
#POLB #SAB #ScientificAdvisory #BoardMember #AIM #Cancer #Oncology #ScientificExpert
BioPartner UK retweeted
And that was the 2025 #BionowAwards! Thank you to all our nominees, attendees and sponsors for making the evening truly special. Now head over to our event summary to check out the full list of award winners!
bionow.co.uk/news/honouring-…
#LifeSciences #Networking #CelebratingSuccess
BioPartner UK retweeted
Develop your leadership and management skills with our 17 free online modules. They share the latest leadership tools to enable you to reflect on and practise new approaches.
Login or register on NIHR Learn to find out more:
learn.nihr.ac.uk/course/view…
ALT E-learning Leadership skills for researchers. Flexible online modules to help you learn the latest insights and study at your own pace. NIHR Learn learn.nihr.ac.uk
BioPartner UK retweeted
The @US_FDA has published a paper on a plausible mechanism pathway, a #regulatory framework to accelerate approval of bespoke, #patient-specific #therapies when traditional trials are not feasible.
-
For more information on this guidance, get in touch: scendea.com/contact
BioPartner UK retweeted
The @US_FDA has published a guidance titled, “Scientific Considerations in Demonstrating #Biosimilarity to a Reference Product: Updated Recommendations for Assessing the Need for Comparative Efficacy Studies (CES)”.
-
#guidanceupdate #scientificconsiderations #USregulatorysupport
BioPartner UK retweeted
Video clips & a post-event update from CEO Jeremy Skillington at this weeks' EBD Group's BIO-Europe in Vienna!
The team were delighted to join so many industry colleagues to explore the future of biotech and pharma.
A big thank you to everyone who took the time to connect with our team. We look forward to continuing the momentum and driving meaningful outcomes in the life sciences.
#POLB #BIOEUROPE #Vienna #Conference #Pharma #Biotech
BioPartner UK retweeted
The #BionowAwards are NOW OPEN for applications until 16 JAN! 🏆
Whether you want to nominate a stellar colleague, celebrate an investment win or showcase that amazing project, ALL are welcome to make a submission.
More info: bionow.glueup.com/event/2025…
#CelebratingSuccess
BioPartner UK retweeted
This week is RSV Awareness Week and at hVIVO, we’re proud to be at the forefront of innovation in RSV research and development. Respiratory Syncytial Virus (RSV) continues to pose a significant global health challenge, particularly for infants, older adults, and immunocompromised individuals. At hVIVO, we provide comprehensive, end-to-end support for the development and evaluation of RSV vaccines and antiviral therapeutics through our world-leading controlled human infection models and specialist laboratory services.
Let’s work together to advance RSV science and protect vulnerable populations.
Learn more about our dedicated RSV human challenge trial services by clicking on the link below or reach out directly on [email protected]:
hvivo.com/human-challenge-mo…
#HVO #RSVWeek #RSV #ClinicalTrials #Vaccines #Antivirals #hLAB
BioPartner UK retweeted
Our CEO provides an overview on the clear plan to deliver shareholder returns through Poolbeg’s strategic & financial highlights.
🔹Our partnering focused model of cost-effective trials have been designed to produce high-quality human data and accelerate partnering discussions on our pipeline.
🔹We have a proven team with expertise in trial execution and deal-making.
🔹Well capitalised with a cash runway into 2027 supporting the delivery of multiple key clinical milestones.
We have multiple potential value catalysts ahead, check out POLB 001’s here:
poolbegpharma.com/pipeline/p…
#POLB #Strategy #Partnering #AIM #London #CashBalance
BioPartner UK retweeted
📸Relive the highlights of #BIOSPAIN2025!
From groundbreaking biotech innovations to record-breaking connections, see how the international biotech community came together in Barcelona.
➡️Access the gallery: asebio.com/en/news-events/ne…
BioPartner UK retweeted
The @US_FDA has introduced a pilot program to expedite the review of #ANDAs submitted by companies that conduct #bioequivalence testing and manufacture generic drug products domestically.
-
To discuss this guidance, get in touch: scendea.com/contact
-
#drugdevelopment
BioPartner UK retweeted
Our Principal Scientist, Liam Tremble, discusses our upcoming POLB 001 first-in-patient phase 2a trial.
✅Trial to be conducted by Accelerating Clinical Trials
🔬 Dr Emma Searle, Consultant Haematologist will be running at the Christie Foundation Trust
👉Number of other leading UK specialist cancer centres will participate
🎯Supply of approved bispecifc antibody secured at no cost to Poolbeg
If you missed this announcement, catch up here:
polaris.brighterir.com/publi…
#POLB #Phase2 #ClinicalTrials #UKTrials #Pharma #CRS #Bispecifics